Assenagon Asset Management S.A. Grows Stock Holdings in Masimo Corporation $MASI

Key Points

• Assenagon Asset Management boosted its stake in Masimo by 2,078.5%, adding 51,068 shares in Q4 to hold 53,525 shares worth about $6.96 million (roughly 0.10% of the company).
• Other institutions also increased exposure—Viking Global opened a new ~$129.1 million stake and Squarepoint raised its position by 738.8% to 620,932 shares—leaving hedge funds and institutions owning about 85.96% of Masimo.
• Analyst sentiment has cooled: several firms have cut ratings (e.g., Raymond James and Piper Sandler), and Masimo carries a consensus rating of "Reduce" with a $181.17 consensus target price.

Assenagon Asset Management S.A. raised its holdings in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 2,078.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,525 shares of the medical equipment provider's stock after acquiring an additional 51,068 shares during the quarter. Assenagon Asset Management S.A. owned about 0.10% of Masimo worth $6,961,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Viking Global Investors LP bought a new stake in Masimo during the second quarter worth about $129,096,000. Squarepoint Ops LLC increased its position in shares of Masimo by 738.8% during the 3rd quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider's stock valued at $91,619,000 after purchasing an additional 546,905 shares during the last quarter. Alyeska Investment Group L.P. raised its holdings in shares of Masimo by 21.7% during the 3rd quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider's stock valued at $203,779,000 after buying an additional 246,595 shares in the last quarter. Westfield Capital Management Co. LP raised its holdings in shares of Masimo by 20.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,419,250 shares of the medical equipment provider's stock valued at $209,410,000 after buying an additional 238,047 shares in the last quarter. Finally, Bank of America Corp DE lifted its position in Masimo by 113.0% in the 3rd quarter. Bank of America Corp DE now owns 405,061 shares of the medical equipment provider's stock worth $59,767,000 after buying an additional 214,885 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on MASI shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a research note on Monday, December 1st. Raymond James Financial lowered shares of Masimo from an "outperform" rating to a "market perform" rating in a report on Friday. Piper Sandler cut shares of Masimo from an "overweight" rating to a "hold" rating and set a $180.00 price objective for the company. in a research note on Tuesday, February 17th. Weiss Ratings reiterated a "sell (d)" rating on shares of Masimo in a research report on Thursday, January 22nd. Finally, Stifel Nicolaus set a $180.00 price target on shares of Masimo in a research note on Tuesday, February 17th. Eight investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Masimo currently has a consensus rating of "Reduce" and a consensus target price of $181.17.

Masimo Stock Up 0.1%

Shares of Masimo stock opened at $177.11 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $179.00. The company's 50 day moving average price is $159.93 and its 200-day moving average price is $148.32. The stock has a market capitalization of $9.51 billion, a price-to-earnings ratio of -16.80, a P/E/G ratio of 1.79 and a beta of 1.21.

Masimo Profile

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.